EcoDrugPlus

Glucokinase (Hexokinase 4)

Ensembl ID : ENSDARG00000068006
Gene Symbol: GCK
5 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Glucose-Dependent Insulinotropic Receptor-Like

Ensembl ID : ENSDARG00000077746
Gene Symbol: LOC100001479
5 Enzyme and pathways 5 Cross references
176 Possible Orthologues:

Glucosidase, Alpha; Acid (Pompe Disease, Glycogen Storage Disease Type Ii)

Ensembl ID : ENSDARG00000090714
Gene Symbol: GAA
7 Enzyme and pathways 3 Cross references
232 Possible Orthologues:

Glucosidase, Beta, Acid

Ensembl ID : ENSDARG00000076058
Gene Symbol: GBA
4 Enzyme and pathways 5 Cross references
255 Possible Orthologues:

Glutamate Ionotropic Receptor Nmda Type Subunit 2b

Ensembl ID : ENSDARG00000079348
Gene Symbol: GRIN2B
6 Cross references
261 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSDARG00000113771
Gene Symbol: GRIK2
6 Cross references
252 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 3

Ensembl ID : ENSDARG00000077715
Gene Symbol: GRIK3
7 Enzyme and pathways 6 Cross references
254 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d-Like

Ensembl ID : ENSDARG00000070620
Gene Symbol: LOC100149482
15 Enzyme and pathways 5 Cross references
213 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSDARG00000021352
Gene Symbol: GRIA1A
20 Enzyme and pathways 5 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSDARG00000032714
Gene Symbol: GRIA1B
5 Cross references
250 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2a

Ensembl ID : ENSDARG00000070173
Gene Symbol: GRIA2A
5 Cross references
244 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSDARG00000052765
Gene Symbol: GRIA2B
9 Enzyme and pathways 5 Cross references
257 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).